Gonadotropin-releasing hormone antagonists are used to treat advanced prostate cancer. They are also used to treat certain gynecologic conditions and are being studied in the treatment of hormone-sensitive breast cancer. Also called GnRH antagonist, LHRH antagonist, and luteinizing hormone-releasing hormone antagonist.

Market Analysis and Insights: Global and United States Gonadotropin-releasing Hormone Antagonists Market
This report focuses on global and United States Gonadotropin-releasing Hormone Antagonists market.
In 2020, the global Gonadotropin-releasing Hormone Antagonists market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In United States the Gonadotropin-releasing Hormone Antagonists market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Gonadotropin-releasing Hormone Antagonists Scope and Market Size
Gonadotropin-releasing Hormone Antagonists market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Gonadotropin-releasing Hormone Antagonists market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Gonadotropin-releasing Hormone Antagonists market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
Peptides
Small Molecules

Segment by Application
Prostate Cancer
Endometriosis
Uterine Fibroids
Female Infertility
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
AbbVie
Takeda
Astellas
Kissei
Veru Inc
Myovant Sciences
AstraZeneca
Ferring Pharmaceuticals
Jiangsu Hengrui Medicine Co